Filter
1412
Text search:
ebola
prevention
Featured
Recommendations
171
New Publications
473
Language
Document type
No document type
786
Studies & Reports
233
Guidelines
174
Manuals
76
Strategic & Response Plan
65
Fact sheets
32
Situation Updates
19
Training Material
13
Infographics
5
Online Courses
4
Brochures
2
Resource Platforms
2
App
1
Countries / Regions
Sierra Leone
207
Liberia
189
Guinea
106
Congo, Democratic Republic of
98
Global
67
Nigeria
66
Senegal
61
Côte d’Ivoire / Ivory Coast
46
Uganda
45
Burkina Faso
44
Rwanda
43
Mali
39
Ghana
35
West and Central Africa
28
Africa
26
South Sudan
25
Western and Central Europe
25
Ethiopia
22
Kenya
22
Niger
20
Chad
20
Cameroon
19
Guinea-Bissau
18
East and Southern Africa
16
Germany
15
South Africa
15
Middle East and North Africa
15
Mozambique
13
India
11
Central African Republic
11
Syria
10
Latin America and the Carribbean
10
Zambia
9
Brazil
9
Angola
9
Russia
9
Togo
7
Yemen
7
Afghanistan
6
Tanzania
6
Bangladesh
6
Malawi
6
Benin
6
Haiti
5
Nepal
5
Namibia
5
Burundi
5
Ukraine
5
South–East Asia Region
5
USA
4
Philippines
4
Pakistan
4
Egypt
4
Myanmar / Burma
4
Eastern Europe and Central Asia
4
Eastern Europe
4
Jordan
3
Lebanon
3
Gambia
3
China
3
Western Pacific Region
3
Asia
3
Vietnam
3
Saudi Arabia
2
Zimbabwe
2
Somalia
2
Cambodia
2
Thailand
2
Sudan
2
Madagascar
2
Mexico
2
Congo-Brazzaville
2
Japan
2
Portugal
2
Spain
2
Iraq
1
Turkey
1
Indonesia
1
Peru
1
Colombia
1
Ecuador
1
Botswana
1
Bolivia
1
Libya
1
Cape Verde
1
Lesotho
1
Sri Lanka
1
Venezuela
1
Palestine
1
Italy
1
Armenia
1
Mongolia
1
Laos
1
Canada
1
Moldova
1
Iran
1
France
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
361
Key Resources
97
Clinical Guidelines
52
Public Health
50
Women & Child Health
36
Pharmacy & Technologies
17
Capacity Building
13
Annual Report MEDBOX
3
Protection & Security
1
Toolboxes
Ebola
503
COVID-19
276
Rapid Response
111
Planetary Health
48
Global Health Education
33
AMR
33
Caregiver
31
Conflict
28
Health Financing Toolbox
27
HIV
25
Mental Health
25
TB
16
Zika
13
Refugee
12
Polio
9
Specific Hazards
9
Pharmacy
9
NTDs
8
Natural Hazards
7
Disability
6
Cholera
3
Social Ethics
2
NCDs
2
It is impossible to address the many complex needs of respiratory virus surveillance with a single surveillance system. Multiple systems, investigations and studies must each be fit-for-purpose to specific priority surveillance objectives, and only together can they provide essential information to
...
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating
...
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t
...
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an annualized rate of 1.0%. While global development ass
...
The 2021 Financing for Sustainable Development Report responds to the request made by Member States to review the impact of the COVID-19 pandemic on nancing for sustainable development, and to propose recommendations to rebuild better. The report underlines the need for policy actions to ensure e e
...
The majority of developing countries will fail to achieve their targets for Universal Health Coverage (UHC)1 and the health- and poverty-related Sustainable Development Goals (SDGs) unless they take urgent steps to strengthen their health financing. Just over a decade out from the SDG deadline of 20
...
The ongoing COVID-19 pandemic has shown that public financial management (PFM) should be an integral part of the response. Effectiveness in financing the health response depends not only on the level of funding but also on the way public funds are allocated and spent, this is determined by the PFM r
...
Since the 1970s, voluntary contributions have become an increasingly important component of WHO's budget. As voluntary contributions tend to be earmarked for donor-specified programmes and projects, there are concerns that this trend has diverted focus away from WHO's strategic priorities, made coor
...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de
...
WHO’s total revenue in 2020 was US$ 4299 million and total expenses were US$ 3561 million, resulting in a surplus of US$ 824 million, which includes finance revenue (e.g. interest and investment income) of US$ 86 million, representing increases of 38% and 15% in revenue and expenses respectively.
...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect
...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
Financing Global Health 2014 is the sixth edition of this annually produced report on global health financing. As in previous years, this report captures trends in development assistance for health (DAH) and government health expenditure (GHE). Health financing is one of IHME’s core research areas
...
: Development assistance for health (DAH) is one of the most important means for Japan to promote
diplomacy with developing countries and contribute to the international community. This study, for the first time,
estimated the gross disbursement of Japan’s DAH from 2012 to 2016 and clarified its
...
In In recent years, China has increased its international engagement in health. Nonetheless, the lack
of data on contributions has limited efforts to examine contributions from China. Existing estimates that track
development assistance for health (DAH) from China have relied primarily on one data
...
Development assistance for health (DAH) is an important part of financing healthcare in low- and middle-income countries. We estimated the gross disbursement of DAH of the 29 Development Assistance Committee (DAC) member countries of the Organisation for Economic Co-operation and Development (OECD)
...
A global Pandemic, Preparedness and Response (RRR) architecture
The annual Development Co-operation Report brings new evidence, analysis and ideas on
sustainable development to members of the OECD Development Assistance Committee (DAC) and the international community more broadly. The objectives are to promote best practices and innovation in development co-ope
...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm
...
